Page last updated: 2024-09-04

rhodioloside and Atherogenesis

rhodioloside has been researched along with Atherogenesis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Chen, L; Lei, X; Li, J; Li, WJ; Liu, X; Wang, K; Xing, SS; Yang, J; Yang, YT1
Cao, Y; Dong, P; Jia, L; Jiang, M; Li, C; Liang, Q; Shi, H; Song, T; Wang, P1
Han, X; Huang, Y; Long, X; Tang, J; Wang, X1
Chen, C; Chen, J; Chi, H; Dou, F; Liu, T; Sun, L; Sun, S; Xing, S1
Chen, YY; Jiang, MM; Liang, QQ; Lu, JX; Shi, H; Wen, SY; Wu, Q; Yao, ZH; Zhu, Y1
Li, J; Zhang, X; Zhu, Z1
Bai, XL; Bian, F; Chi, JY; Jin, S; Li, WJ; Li, YS; Wu, D; Wu, GJ; Xing, SS; Yang, XY; Zhang, CT; Zhang, YH; Zhang, YZ; Zheng, T1

Other Studies

7 other study(ies) available for rhodioloside and Atherogenesis

ArticleYear
Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis.
    Inflammation, 2020, Volume: 43, Issue:2

    Topics: Animals; Atherosclerosis; Dose-Response Relationship, Drug; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Knockout; Phenols; Plaque, Atherosclerotic; Pyroptosis; Rhodiola

2020
Salidroside simultaneously reduces de novo lipogenesis and cholesterol biosynthesis to attenuate atherosclerosis in mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 134

    Topics: 3-Hydroxybutyric Acid; Animals; Anticholesteremic Agents; Atherosclerosis; Cholesterol; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Glucose; Glucosides; Glycogen; Hypercholesterolemia; Lipidomics; Lipogenesis; Liver; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Phenols; Proton Magnetic Resonance Spectroscopy

2021
Salidroside inhibits endothelial‑mesenchymal transition via the KLF4/eNOS signaling pathway.
    Molecular medicine reports, 2021, Volume: 24, Issue:4

    Topics: Atherosclerosis; Cell Line; Cell Movement; Down-Regulation; Endothelial Cells; Glucosides; Humans; Kruppel-Like Factor 4; Nitric Oxide; Nitric Oxide Synthase Type III; Phenols; RNA, Small Interfering; Signal Transduction

2021
Salidroside slows the progression of EA.hy926 cell senescence by regulating the cell cycle in an atherosclerosis model.
    Molecular medicine reports, 2018, Volume: 17, Issue:1

    Topics: Animals; Atherosclerosis; Biomarkers; Cell Cycle; Cell Cycle Proteins; Cell Line; Cellular Senescence; Disease Models, Animal; Endothelial Cells; Gene Expression Regulation; Genes, p53; Glucosides; Humans; Phenols

2018
Modulation of hepatic lipidome by rhodioloside in high-fat diet fed apolipoprotein E knockout mice.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2020, Volume: 69

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Chromatography, Liquid; Diet, High-Fat; Dyslipidemias; Glucosides; Lipid Metabolism; Lipids; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Knockout, ApoE; Phenols; Tandem Mass Spectrometry

2020
Salidroside protects against ox-LDL-induced endothelial injury by enhancing autophagy mediated by SIRT1-FoxO1 pathway.
    BMC complementary and alternative medicine, 2019, May-30, Volume: 19, Issue:1

    Topics: Atherosclerosis; Autophagy; Drug Evaluation, Preclinical; Endothelial Cells; Forkhead Box Protein O1; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; Oxidative Stress; Phenols; Phytotherapy; Plant Extracts; Rhodiola; Sirtuin 1

2019
Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway.
    Vascular pharmacology, 2015, Volume: 72

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Atherosclerosis; Diet, High-Fat; Endothelial Cells; Glucosides; Male; Mice; Mitochondria; Nitric Oxide; Nitric Oxide Synthase Type III; Phenols; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction

2015